{"document_type": "article", "snippet": "At a technology conference, the company\u2019s chief executive addressed recent reports that questioned the reliability of its tests.", "type_of_material": "News", "web_url": "http://www.nytimes.com/2015/10/22/technology/theranos-elizabeth-holmes.html", "subsection_name": null, "blog": [], "section_name": "Technology", "source": "The New York Times", "pub_date": "2015-10-22T00:00:00Z", "word_count": "1272", "slideshow_credits": null, "news_desk": "Business", "byline": {"person": [{"role": "reported", "lastname": "BENNER", "rank": 1, "organization": "", "firstname": "Katie"}, {"role": "reported", "lastname": "POLLACK", "rank": 2, "organization": "", "firstname": "Andrew"}], "contributor": "Katie Benner reported from Laguna Beach, and Andrew Pollack from Los Angeles. Mike Isaac contributed reporting from New York.", "original": "By KATIE BENNER and ANDREW POLLACK"}, "abstract": "Elizabeth Holmes, founder of $9 billion blood testing laboratory firm Theranos, is embroiled in public fracas to defend her reputation and her closely watched Silicon Valley firm; Wall Street Journal questions accuracy of company's blood tests and whether technology is truly unique. ", "keywords": [{"value": "Tests (Medical)", "rank": "1", "name": "subject", "is_major": "Y"}, {"value": "Theranos Inc", "rank": "2", "name": "organizations", "is_major": "Y"}, {"value": "Holmes, Elizabeth (1984- )", "rank": "3", "name": "persons", "is_major": "Y"}, {"value": "Blood", "rank": "4", "name": "subject", "is_major": "N"}, {"value": "Wall Street Journal", "rank": "5", "name": "organizations", "is_major": "N"}, {"value": "Start-ups", "rank": "6", "name": "subject", "is_major": "N"}, {"value": "Food and Drug Administration", "rank": "7", "name": "organizations", "is_major": "N"}], "print_page": "1", "multimedia": [{"subtype": "wide", "legacy": {"wideheight": "126", "wide": "images/2015/10/22/business/22THERANOS/22THERANOS-thumbWide.jpg", "widewidth": "190"}, "type": "image", "width": 190, "height": 126, "url": "images/2015/10/22/business/22THERANOS/22THERANOS-thumbWide.jpg"}, {"subtype": "xlarge", "legacy": {"xlargeheight": "681", "xlargewidth": "600", "xlarge": "images/2015/10/22/business/22THERANOS/22THERANOS-articleLarge.jpg"}, "type": "image", "width": 600, "height": 681, "url": "images/2015/10/22/business/22THERANOS/22THERANOS-articleLarge.jpg"}, {"subtype": "thumbnail", "legacy": {"thumbnail": "images/2015/10/22/business/22THERANOS/22THERANOS-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "type": "image", "width": 75, "height": 75, "url": "images/2015/10/22/business/22THERANOS/22THERANOS-thumbStandard.jpg"}], "lead_paragraph": "At a technology conference, the company\u2019s chief executive addressed recent reports that questioned the reliability of its tests.", "headline": {"print_headline": "Blood Lab That Boasts Breakthrough Goes on Defense Against Its Doubters", "main": "Theranos, a Blood Testing Start-Up, Defends Its Accuracy"}, "_id": "5627cfa938f0d80f1ae08a80"}